松嶋ゆかり

Matsushima Yukari

研究分野 (2件)：環境、天然医薬資源学 , 薬理学

研究キーワード (3件)：漢方薬 , シグマ受容体 , 神経薬理

論文 (5件)：

Kazuki Terada, Keisuke Migita, Yukari Matsushima, Chiaki Kamei. Sigma-2 receptor as a potential therapeutic target for treating central nervous system disorders. Neural Regeneration Research. 2019. 14. 11. 1893-1894
Yukari Matsushima, Kazuki Terada, Chiaki Kamei, Yumi Sugimoto. Sertraline inhibits nerve growth factor-induced neurite outgrowth in PC12 cells via a mechanism involving the sigma-1 receptor. European Journal of Pharmacology. 2019. 853. 129-135
Yukari Matsushima, Kazuki Terada, Jiro Takata, Yoshiharu Karube, Chiaki Kamei, Yumi Sugimoto. Effects of fluvoxamine on nerve growth factor-induced neurite outgrowth inhibition by dexamethasone in PC12 cells. Bioscience, Biotechnology, and Biochemistry. 2019. 83. 4. 659-665
Kazuki Terada, Keisuke Migita, Yukari Matsushima, Yumi Sugimoto, Chiaki Kamei, Taichi Matsumoto, Masayoshi Mori, Kazuhisa Matsunaga, Jiro Takata, Yoshiharu Karube. Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors. PLOS ONE. 2018. 13. 12. e0209250-e0209250
Kazuki Terada, Yukari Matsushima, Kazuhisa Matsunaga, Jiro Takata, Yoshiharu Karube, Atsushi Ishige, Koji Chiba. The Kampo medicine Yokukansan (YKS) enhances nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. Bosnian Journal of Basic Medical Sciences. 2018. 18. 3. 224-233

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

松嶋 ゆかり